Sorted By:

Relevance


Comprehensive Health Care Reform Should Be National Priority

PhRMA  |  Press Release

Washington, D.C. (September 9, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin issued the following statement after President Obama’s address to a joint session of Congress o...
https://www.phrma.org/press-release/comprehensive-health-care-reform-should-be-national-priority

PhRMA Statement: Drug Quality and Security Act

PhRMA  |  Press Release

Washington, D.C. (November 18, 2013) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J Castellani issued the following statement: “PhRMA is pleased that the Senate has passed the Drug Quality and Security Act and that the bill will now...
https://www.phrma.org/press-release/phrma-statement-drug-quality-and-security-act

Nearly 200 Medicines in Development for Mental Illnesses

PhRMA  |  Press Release

A separate report specific to Alzheimer’s will be released later in the year.
https://www.phrma.org/press-release/nearly-200-medicines-in-development-for-mental-illnesses

PhRMA Statement on MedPAC April Recommendations and Vote

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-statement-on-medpac-april-recommendations-and-vote

Biopharmaceutical Sector Supports Nearly 84,000 Florida Jobs

PhRMA  |  Press Release

The report was released today at a conference in Tampa sponsored by BioFlorida on the importance of life sciences and biopharmaceutical research to the state. 
https://www.phrma.org/press-release/biopharmaceutical-sector-supports-nearly-84-000-florida-jobs

PhRMA Applauds G8 Action on Anti-Counterfeiting

PhRMA  |  Press Release

“PhRMA especially applauds the leadership of President Obama to bring this initiative to the G8.
https://www.phrma.org/press-release/phrma-applauds-g8-action-on-anti-counterfeiting

PhRMA Statement Regarding Puerto Rico Law 154

PhRMA  |  Press Release

(October 25, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President John Castellani [bio] released the following statement about Law 154, which was signed today in Puerto Rico: “PhRMA member companies have long had a strong presence in Puerto Rico, providing thousands of stable, high-paying jobs and investment in local economies in the search for new medicines.
https://www.phrma.org/press-release/phrma-statement-regarding-puerto-rico-law-154

PhRMA Statement on the Earthquake in Japan

PhRMA  |  Press Release

Castellani today released the following statement: “PhRMA and our member companies express our deepest sympathy for the people of Japan during this very difficult time, especially those who have lost loved ones.
https://www.phrma.org/press-release/phrma-statement-on-the-earthquake-in-japan

Matt Bennett Joins PhRMA as Senior VP, Communications

PhRMA  |  Press Release

Washington, D.C. (June 13, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Matthew D. Bennett has been named Senior Vice President of Communications and Public Affairs, effective today. Bennett will report to Executive Vice President ...
https://www.phrma.org/press-release/matt-bennett-joins-phrma-as-senior-vp-communications

PhRMA Statement on Partnership to Support Innovation

PhRMA  |  Press Release

Washington, D.C. (February 24, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding efforts to encourage medical progress: “PhRMA...
https://www.phrma.org/press-release/phrma-statement-on-partnership-to-support-innovation

PhRMA Response to Senate Finance Committee Draft Summary

PhRMA  |  Press Release

Washington, D.C. (September 8, 2009) — In response to a draft summary circulated by the Senate Finance Committee, Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice P...
https://www.phrma.org/press-release/phrma-response-to-senate-finance-committee-draft-summary

PhRMA Statement on Personalized Medicine Research

PhRMA  |  Press Release

Washington, D.C. (November 16, 2010) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Wes Metheny issued the following statement today regarding the Tufts Center for the Study of Drug Development Impact Report on personalized medicine research:...
https://www.phrma.org/press-release/phrma-statement-on-personalized-medicine-research

Sino-Phirda and PhRMA Sign Joint Cooperation Agreement

PhRMA  |  Press Release

Washington, D.C. (November 19, 2010) — Following a two day conference in Washington, DC, the China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA) and the Pharmaceutica...
https://www.phrma.org/press-release/sino-phirda-and-phrma-sign-joint-cooperation-agreement

PhRMA Statement on House Patent Bill

PhRMA  |  Press Release

Washington, D.C. (May 17, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson today issued the following statement regarding a proposal to allow the Patent and Trademark Office to collect fees on patent applications: “Rep....
https://www.phrma.org/press-release/phrma-statement-on-house-patent-bill

PhRMA Statement on Medicare Part D Premiums

PhRMA  |  Press Release

Washington, D.C. (August 7, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on the continued success of Medicare Part D: “Since its inception, Medicare Part D has provided good ...
https://www.phrma.org/press-release/phrma-statement-on-medicare-part-d-premiums

PhRMA Statement on AARP Prescription Drug Report

PhRMA  |  Press Release

Washington, D.C. (November 16, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today:  “In AARP’s skewed view of the world, medicines are always looked at as a cost and never seen as a sa...
https://www.phrma.org/press-release/phrma-statement-on-aarp-prescription-drug-report

Un informe describe diversos medicamentos nuevos en desarrollo para combatir la epidemia de diabetes que afecta a más de 30 millones de estadounidenses

PhRMA  |  Press Release

WASHINGTON, D.C. (14 de noviembre 2016) — Un nuevo informe difundido hoy por Pharmaceutical Research and Manufacturers of America (PhRMA) señala el progreso y el esfuerzo continuos realiza...
https://www.phrma.org/press-release/medicamentos-en-desarrollo-para-la-diabetes

PhRMA Statement on Supporting Safe Disposal Resources

PhRMA  |  Press Release

  For more information on PhRMA’s broad range of efforts regarding prevention of prescription drug abuse and diversion, please visit PhRMA’s website at www.phrma.org. 
https://www.phrma.org/press-release/phrma-statement-on-supporting-safe-disposal-resources

Robert Zirkelbach Named PhRMA Executive Vice President

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/robert-zirkelbach-named-phrma-executive-vice-president

Comprehensive Health Reform: A Must Pass This Year

PhRMA  |  Press Release

(February 25, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement regarding President Obama’s address to a joint session of Congress last night: “PhRMA applauds President Obama for making clear that comprehensive healthcare reform is a top priority for his administration.
https://www.phrma.org/press-release/comprehensive-health-reform-a-must-pass-this-year

PhRMA Welcomes Five New Member Companies

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-welcomes-five-new-member-companies

PhRMA Response to Colombia’s Issuance of a Declaration of Public Interest

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-response-to-colombia-s-issuance-of-a-declaration-of-public-interest

PhRMA Statement on Senate Finance Committee Vote

PhRMA  |  Press Release

(October 13, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin released the following statement about the Senate Finance Committee’s vote on Chairman Baucus’ health care reform proposal: “Today’s vote represents an important step forward for the millions of Americans who don’t have access to high-quality and affordable health care coverage and services.
https://www.phrma.org/press-release/phrma-statement-on-senate-finance-committee-vote

PhRMA Statement on the FDA and NIH Workforce Authorities Modernization Act

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-statement-on-the-fda-and-nih-workforce-authorities-modernization-act

PhRMA Applauds Tenure of FDA Commissioner Hamburg

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-applauds-tenure-of-fda-commissioner-hamburg

You have reviewed the first 225 results out of 880. Each page contains 25 results. You're on page 9.

prev 7 8 9 10 11 12 next